Skip to main content

Advertisement

SpringerLink
Log in

Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study is to identify metastasis-associated genes/signaling pathways in basal-like breast tumors. Kaplan–Meier analysis of two public meta-datasets and functional classification was used to identify genes/signaling pathways significantly associated with distant metastasis free survival. Integrated analysis of expression correlation and interaction between mRNAs and miRNAs was used to identify miRNAs that potentially regulate the expression of metastasis-associated genes. The novel metastatic suppressive role of miR-17-5p was examined by in vitro and in vivo experiments. Over 4,000 genes previously linked to breast tumor progression were examined, leading to identification of 61 and 69 genes significantly associated with shorter and longer DMFS intervals of patients with basal-like tumors, respectively. Functional annotation linked most of the pro-metastatic genes to epithelial mesenchymal transition (EMT) process and three intertwining EMT-driving pathways (hypoxia, TGFB and Wnt), whereas most of the anti-metastatic genes to interferon signaling pathway. Members of three miRNA families (i.e., miR-17, miR-200 and miR-96) were identified as potential regulators of the pro-metastatic genes. The novel anti-metastatic function of miR-17-5p was confirmed by in vitro and in vivo experiments. We demonstrated that miR-17-5p inhibition in breast cancer cells enhanced expression of multiple pro-metastatic genes, rendered cells metastatic properties, and accelerated lung metastasis from orthotopic xenografts. In contrast, intratumoral administration of miR-17-5p mimic significantly reduced lung metastasis. These results provide evidence supporting that EMT activation and IFN pathway inactivation are markers of metastatic progression of basal-like tumors, and members of miR-17, miR-200, and miR-96 families play a role in suppressing EMT and metastasis. The metastasis-associated genes identified in this study have potential prognostic values and functional implications, thus, can be exploited as therapeutic targets to prevent metastasis of basal-like breast tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Society AC (2013–2014) Breast cancer facts & figures

  2. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27:1160–1167. doi:10.1200/JCO.2008.18.1370

    Article  PubMed Central  PubMed  Google Scholar 

  3. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68. doi:10.1186/bcr2635

    Article  PubMed Central  PubMed  Google Scholar 

  4. Santagata S, Thakkar A, Ergonul A, Wang B, Woo T, Hu R, Harrell JC, McNamara G, Schwede M, Culhane AC, Kindelberger D, Rodig S, Richardson A, Schnitt SJ, Tamimi RM, Ince TA (2014) Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Investig 124:859–870. doi:10.1172/JCI70941

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM (2013) Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 15:274–283. doi:10.1038/ncb2697

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Ince TA, Richardson AL, Bell GW, Saitoh M, Godar S, Karnoub AE, Iglehart JD, Weinberg RA (2007) Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12:160–170. doi:10.1016/j.ccr.2007.06.013

    Article  CAS  PubMed  Google Scholar 

  7. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA, Martens JW (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68:3108–3114. doi:10.1158/0008-5472.CAN-07-5644

    Article  CAS  PubMed  Google Scholar 

  8. Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61–70. doi:10.1038/nature11412

    Article  Google Scholar 

  9. Ellis MJ, Perou CM (2013) The genomic landscape of breast cancer as a therapeutic roadmap. Cancer Discov 3:27–34. doi:10.1158/2159-8290.CD-12-0462

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Metzger-Filho O, Sun Z, Viale G, Price KN, Crivellari D, Snyder RD, Gelber RD, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Cardoso F (2013) Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 31:3083–3090. doi:10.1200/JCO.2012.46.1574

    Article  CAS  PubMed  Google Scholar 

  11. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, Griffith M, Moradian A, Cheng SW, Morin GB, Watson P, Gelmon K, Chia S, Chin SF, Curtis C, Rueda OM, Pharoah PD, Damaraju S, Mackey J, Hoon K, Harkins T, Tadigotla V, Sigaroudinia M, Gascard P, Tlsty T, Costello JF, Meyer IM, Eaves CJ, Wasserman WW, Jones S, Huntsman D, Hirst M, Caldas C, Marra MA, Aparicio S (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486:395–399. doi:10.1038/nature10933

    CAS  PubMed  Google Scholar 

  12. Van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536. doi:10.1038/415530a

    Article  Google Scholar 

  13. Landemaine T, Jackson A, Bellahcene A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebretiere JM, Ricevuto E, Nogues C, Briffod M, Bieche I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K (2008) A six-gene signature predicting breast cancer lung metastasis. Cancer Res 68:6092–6099. doi:10.1158/0008-5472.CAN-08-0436

    Article  CAS  PubMed  Google Scholar 

  14. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524. doi:10.1038/nature03799

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massague J (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459:1005–1009. doi:10.1038/nature08021

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Culhane AC, Quackenbush J (2009) Confounding effects in “A six-gene signature predicting breast cancer lung metastasis”. Cancer Res 69:7480–7485. doi:10.1158/0008-5472.CAN-08-3350

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271–3277. doi:10.1200/JCO.2009.25.9820

    Article  PubMed  Google Scholar 

  18. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671–679. doi:10.1016/S0140-6736(05)17947-1

    Article  CAS  PubMed  Google Scholar 

  19. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig 121:2750–2767. doi:10.1172/JCI45014

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15:907–913. doi:10.1038/nm.2000

    Article  CAS  PubMed  Google Scholar 

  21. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, Mani SA (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107:15449–15454. doi:10.1073/pnas.1004900107

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J (2011) GOBO: gene expression-based outcome for breast cancer online. PLoS ONE 6:e17911. doi:10.1371/journal.pone.0017911

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123:725–731. doi:10.1007/s10549-009-0674-9

    Article  PubMed  Google Scholar 

  24. Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, Chapman R, Hertzog PJ (2013) Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41:D1040–D1046. doi:10.1093/nar/gks1215

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40:294–309. doi:10.1016/j.molcel.2010.09.022

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13:616–630. doi:10.1038/nrm3434

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Pencheva N, Tavazoie SF (2013) Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15:546–554. doi:10.1038/ncb2769

    Article  CAS  PubMed  Google Scholar 

  28. Fan M, Krutilina R, Sun J, Sethuraman A, Yang CH, Wu ZH, Yue J, Pfeffer LM (2013) Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells. J Biol Chem 288:27480–27493. doi:10.1074/jbc.M113.491803

  29. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, Kreike B, Sie D, Hovestadt V, Wessels LF, van de Vijver MJ, Tuschl T (2011) MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71:4443–4453. doi:10.1158/0008-5472.CAN-11-0608

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894–907. doi:10.1101/gad.1640608

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Li XL, Hara T, Choi Y, Subramanian M, Francis P, Bilke S, Walker RL, Pineda M, Zhu Y, Yang Y, Luo J, Wakefield LM, Brabletz T, Park BH, Sharma S, Chowdhury D, Meltzer PS, Lal A (2014) A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 34:533–550. doi:10.1128/MCB.01043-13

  32. Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY, Furth E, Enders GH, El-Deiry W, Schelter JM, Cleary MA, Thomas-Tikhonenko A (2010) The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res 70:8233–8246. doi:10.1158/0008-5472.CAN-10-2412

  33. Vanharanta S, Massague J (2013) Hypoxia signaling–license to metastasize. Cancer Discov 3:1103–1104. doi:10.1158/2159-8290.CD-13-0481

    Article  CAS  PubMed  Google Scholar 

  34. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP (2011) Molecular signatures database (MsigDB) 3.0. Bioinformatics 27:1739–1740. doi:10.1093/bioinformatis/btr260

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342:1234850. doi:10.1126/science.1234850

    Article  PubMed  Google Scholar 

  36. Lu X, Kang Y (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16:5928–5935. doi:10.1158/1078-0432.CCR-10-1360

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Luga V, Wrana JL (2013) Tumor–stroma interaction: revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. Cancer Res 73:6843–6847. doi:10.1158/0008-5472.CAN-13-1791

    Article  CAS  PubMed  Google Scholar 

  38. Macheda ML, Sun WW, Kugathasan K, Hogan BM, Bower NI, Halford MM, Zhang YF, Jacques BE, Lieschke GJ, Dabdoub A, Stacker SA (2012) The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling. J Biol Chem 287:29312–29323. doi:10.1074/jbc.M112.362681

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Wang Y (2009) Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 8:2103–2109. doi:10.1158/1535-7163.MCT-09-0282

    Article  CAS  PubMed  Google Scholar 

  40. Green J, Nusse R, van Amerongen R (2014) The role of ryk and ror receptor tyrosine kinases in wnt signal transduction. Cold Spring Harbor perspectives in biology, vol 6. doi:10.1101/cshperspect.a009175

  41. Zhang P, Cai Y, Soofi A, Dressler GR (2012) Activation of Wnt11 by transforming growth factor-beta drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem 287:21290–21302. doi:10.1074/jbc.M112.357202

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Fox JL, Dews M, Minn AJ, Thomas-Tikhonenko A (2013) Targeting of TGFbeta signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. RNA 19:177–190. doi:10.1261/rna.036467.112

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107:8231–8236. doi:10.1073/pnas.1002080107

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D’Andrea A, Sander C, Ventura A (2009) Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23:2806–2811. doi:10.1101/gad.1872909

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Becker LE, Lu Z, Chen W, Xiong W, Kong M, Li Y (2012) A systematic screen reveals MicroRNA clusters that significantly regulate four major signaling pathways. PLoS ONE 7:e48474. doi:10.1371/journal.pone.0048474

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Jin HY, Oda H, Lai M, Skalsky RL, Bethel K, Shepherd J, Kang SG, Liu WH, Sabouri-Ghomi M, Cullen BR, Rajewsky K, Xiao C (2013) MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J 32:2377–2391. doi:10.1038/emboj.2013.178

    Article  CAS  PubMed  Google Scholar 

  47. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68–79. doi:10.1016/j.cell.2012.08.033

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Alfano D, Votta G, Schulze A, Downward J, Caputi M, Stoppelli MP, Iaccarino I (2010) Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor. Mol Cell Biol 30:1838–1851. doi:10.1128/MCB.01442-09

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, Bishop JM (2012) MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits. Nat Cell Biol 14:567–574. doi:10.1038/ncb2491

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 14:5158–5165. doi:10.1158/1078-0432.CCR-07-4756

    Article  CAS  PubMed  Google Scholar 

  51. Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C (2007) An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol 8:R157. doi:10.1186/gb-2007-8-8-r157

    Article  PubMed Central  PubMed  Google Scholar 

  52. Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, Andrews D, Mikeska T, Mangan NE, Samarajiwa SA, de Weerd NA, Gould J, Argani P, Moller A, Smyth MJ, Anderson RL, Hertzog PJ, Parker BS (2012) Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med 18:1224–1231. doi:10.1038/nm.2830

    Article  CAS  PubMed  Google Scholar 

  53. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675

    Article  CAS  PubMed  Google Scholar 

  54. Spandidos A, Wang X, Wang H, Seed B (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38:D792–D799. doi:10.1093/nar/gkp1005

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28:771–776. doi:10.1093/bioinformatics/bts043

    Article  CAS  PubMed  Google Scholar 

  56. Wang X, El Naqa IM (2008) Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24:325–332. doi:10.1093/bioinformatics/btm595

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH Grants, CA140346 (to Meiyun Fan).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, 19 South Manassas Street, Memphis, TN, 38163, USA

    Meiyun Fan, Aarti Sethuraman & Lawrence M. Pfeffer

  2. Center for Cancer Research, Memphis, TN, 38163, USA

    Meiyun Fan, Aarti Sethuraman, Martin Brown & Lawrence M. Pfeffer

  3. Department of Pharmacology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA

    Wenlin Sun

Authors
  1. Meiyun Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aarti Sethuraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wenlin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lawrence M. Pfeffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meiyun Fan.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, M., Sethuraman, A., Brown, M. et al. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. Breast Cancer Res Treat 146, 487–502 (2014). https://doi.org/10.1007/s10549-014-3040-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3040-5

Keywords

Search

Navigation